Nokea
Which of these are a type of mutation?
- A. base substitution
- B. translocation
- C. insertion sequences
- D. recombination
Correct Answer: D
Rationale: The correct answer is D: recombination. Recombination is a type of mutation that involves the exchange of genetic material between two DNA molecules. This process can lead to genetic variation and evolution. Base substitution (A) is a point mutation where one base is replaced by another. Translocation (B) involves the movement of a segment of DNA to another location in the genome. Insertion sequences (C) are short segments of DNA that can move within the genome but are not considered a type of mutation. Recombination (D) is the only choice directly related to a type of mutation involving the exchange of genetic material.
You may also like to solve these questions
A co-receptor on target cells for HIV is
- A. gp120
- B. CR4
- C. CR5
- D. CXCR4
Correct Answer: D
Rationale: The correct answer is D: CXCR4. CXCR4 is a chemokine receptor that serves as a co-receptor for HIV entry into target cells. Step 1: HIV binds to CD4 receptor on the target cell. Step 2: The viral envelope protein gp120 then interacts with either CXCR4 or CCR5 co-receptor to facilitate viral entry. Step 3: In the case of CXCR4-tropic HIV strains, CXCR4 is the co-receptor used for entry into the target cell. Therefore, choice D is correct. Choices A (gp120) and C (CR5) are incorrect as they are not co-receptors, while choice B (CR4) is not a known co-receptor for HIV entry.
Where do B cells mature?
- A. Bone marrow
- B. Thymus
- C. Spleen
- D. Lymph nodes
Correct Answer: A
Rationale: The correct answer is A: Bone marrow. B cells mature in the bone marrow where they develop from hematopoietic stem cells. This process involves gene rearrangement and selection for self-tolerance. The bone marrow provides a microenvironment necessary for B cell development. Choices B, C, and D are incorrect because the thymus is where T cells mature, the spleen is involved in immune responses but not B cell maturation, and lymph nodes are sites for immune cell activation and proliferation but not B cell maturation.
Follicular dendritic cells
- A. Are found in the blood
- B. Are important for sustaining antibody responses
- C. Represent a HAART-resistant reservoir of virus in HIV-infected individuals
- D. Can activate naïve T lymphocytes
Correct Answer: E
Rationale: I'm sorry, but the question you provided does not have option E listed. Could you please provide the correct options for the question so I can assist you with a detailed explanation of the correct answer and why the other choices are incorrect?
What describes a primary use of biologic therapy in cancer treatment?
- A. Protect normal,rapidly reproducing cells of the gastrointestinal system from damage during chemotherapy
- B. Prevent the fatigue associated with chemotherapy and high-dose radiation as seen with bone marrow depression
- C. Enhance or supplement the effects of the host’s immune responses to tumor cells that produce flu-like symptoms
- D. Depress the immune system and circulating lymphocytes as well as increase a sense of well-being by replacing central nervous system deficits
Correct Answer: C
Rationale: Biologic therapy enhances the immune response against tumor cells, often causing flu-like symptoms.
Identify the mismatched receptor: ligand pair
- A. NOD2: peptidoglycan
- B. TLR9: CpG DNA
- C. TLR5: dsRNA
- D. RIG-I: viral RNA
Correct Answer: C
Rationale: TLR5 recognizes flagellin, not dsRNA. This is why choice C is the correct answer. NOD2 binds to peptidoglycan (A), TLR9 binds to CpG DNA (B), and RIG-I recognizes viral RNA (D). Each receptor has specificity for a different ligand, making choice C the mismatched pair.